1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Cancer Drug News 09 NOVEMBER 2015

Cancer Drug News 09 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Trend Analysis - Sanofi Targets Oncology For Growth
Industry Brief - EC Approves Vidaza For Elderly AML Population
Industry Brief - Viralytics/Merck Collaborate On Immunotherapy Combination
Industry Brief - Merck KGaA/Pfizer Initiate Avelumab Phase III Trial In Stage IV NSCLC
Industry Brief - EMA Validates Type II Variation Application For Opdivo In Previously-Treated Advanced RCC
Industry Brief - ASLAN/Hyundai Sign South Korean ASLAN001 Licensing Deal In CCA
Industry Brief - Ignyta Acquires Global Rights To Lilly's Taladegib Oncology Programme
Industry Brief - Daiichi Sankyo/Plexxikon's Pexidartinib Gains FDA Breakthrough Therapy Designation For TGCT
Industry Brief - Kura Raises Funds In Public Offering
Industry Brief - GSK/Merck Initiate Immunotherapy Combination Trial
Industry Trend Analysis - AbbVie Portfolio Shift Will Be Gradual
Industry Brief - Pivot To Acquire IndUS Pharmaceuticals

Table Of Contents

Cancer Drug News 09 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.